1.What intensive care unit readmission means.
Allergy, Asthma & Respiratory Disease 2014;2(2):83-84
No abstract available.
Intensive Care Units*
2.Is Percutaneous Dilatational Tracheostomy Safe to Perform in the Intensive Care Unit?.
The Korean Journal of Critical Care Medicine 2014;29(2):57-58
No abstract available.
Intensive Care Units*
;
Tracheostomy*
3.Colistin-associated nephrotoxicity among patients in intensive care units (ICU) of hospitals in Selangor
Rashizal Sazli Mohd Rasidin ; Ami Fazlin Syed Mohamed ; Wan Mazuan Wan Mahmud ; Ling Siew Mei ; Aidalina Mahmud ; Syafinaz Amin Nordin
The Medical Journal of Malaysia 2017;72(2):100-105
Introduction: The increasing trend of extensively drugresistant
gram negative bacteria responsible for nosocomial
infections has prompted resurgence colistin usage.
Colistin-induced nephrotoxicity is a concern with disparity
in the reported rates between previous studies. This study
aims to evaluate colistin-induced nephrotoxicity among
Malaysian population.
Methods: The medical records of ICU patients receiving
colistin therapy in Hospital Serdang and Hospital Sungai
Buloh from 2010 to 2012 were retrospectively reviewed.
Demographics data, treatment characteristic as well as
culture result and creatinine level were documented.
Nephrotoxicity was determined based on RIFLE criteria.
Results: A total of 100 patients were included. Median daily
dose, cumulative dose and duration of colistin therapy were
3.0 MIU (IQR: 4, range 1-12), 17.8 MIU (IQR: 31.5, range 2-180)
and seven days (IQR: 4, range 1-30). Nephrotoxicity was
found in 23% of the study population. All cases were
reversible but marginally associated with higher mortality.
No statistical association exist between age, gender and
race as well as administration routes with nephrotoxicity by
univariable analysis. The association of dose and duration
with nephrotoxicity was also not significant by univariable
analysis. After adjustment for confounders, statistical
association between the independent variables and
dependent variable remains not significant.
Conclusion: Lower dose and shorter duration in local
settings contribute to lack of association between colistin
therapy and nephrotoxicity in this study. Higher dosing
regimen with loading dose application has been introduced
in the latest National Antibiotic Guideline. Further
evaluation of colistin-induced nephrotoxicity and potential
risk factors is therefore warranted.
Colistin
;
Intensive Care Units
4.Evaluation of effectiveness and safety of an ICU insulin infusion protocol
Queenie Ngalob ; Cecilia Jimeno ; Iris Thiele Isip-Tan
Journal of the ASEAN Federation of Endocrine Societies 2014;29(1):33-41
Objective:
To evaluate the efficacy, safety, and clinical outcomes of, and protocol deviations with the use of the Modified Yale Insulin Infusion Protocol (IIP) compared to usual/standard care in the local setting.
Methods:
Chart review of patients admitted in two ICUs over a 2-year period was done. Patients eligible for intensive glycemic control were identified. Efficacy, safety and clinical outcomes were compared between the Modified Yale IIP and usual/standard care. Charts managed with the IIP were appraised for protocol deviations.
Results:
Eighty-one patients met the inclusion criteria and 34.6% used the IIP. The IIP group achieved a lower mean blood glucose (185.1 vs 212.1 mg/dl, p<0.05). They reached normoglycemia (5 vs 12 hours, p<0.05) and target range of 140-180 mg/dl (8.3 vs 18.3 hours, p<0.05) earlier. Hypoglycemia was rare (median 0%) in both groups. No difference in mortality or morbidity was seen. Hospital (13.9 vs 8.1 days, p<0.05) and ICU stay (5.5 vs 3.0 days, p<0.05) were longer in the IIP group. A mean of 11 deviations per patient occurred, the majority of which were errors on insulin dose administered (66.6%).
Conclusion
The Modified Yale IIP is efficaceous, safe and yielded better glycemic profiles than usual care. Majority of protocol deviations were on the insulin dose administered
Hyperglycemia
;
Intensive Care Units
6.A study of perceived discomfort of intensive care unit patient..
Journal of Korean Academy of Adult Nursing 1992;4(2):209-223
No abstract available.
Intensive Care Units*
;
Critical Care*
7.Hemorrhagic Complications in Intensive Care Unit.
The Korean Journal of Critical Care Medicine 2001;16(2):100-111
No abstract available.
Intensive Care Units*
;
Critical Care*
8.Control of Vancomycin-resistant Enterococci (VRE) in Intensive Care Units.
Korean Journal of Nosocomial Infection Control 2008;13(2):51-63
No abstract available.
Critical Care
;
Intensive Care Units
10.Sedation in the Intensive Care Unit.
The Korean Journal of Critical Care Medicine 2004;19(1):1-7
No abstract available.
Intensive Care Units*
;
Critical Care*